Prominence of nestin-expressing Schwann cells in bone marrow of patients with myelodysplastic syndromes with severe fibrosis.


Journal

International journal of hematology
ISSN: 1865-3774
Titre abrégé: Int J Hematol
Pays: Japan
ID NLM: 9111627

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 25 10 2018
accepted: 10 12 2018
revised: 05 12 2018
pubmed: 12 1 2019
medline: 7 3 2019
entrez: 12 1 2019
Statut: ppublish

Résumé

Nestin-expressing stromal cells (NESCs) and Schwann cells in the bone marrow (BM) play crucial roles as a niche for normal hematopoietic stem cells in mice. It has been reported that both types of cells are decreased in myeloproliferative neoplasms in patients and also in a mouse model, whereas an increase in NESCs was reported in acute myeloid leukemia. It is thus of interest whether and how these BM stromal cells are structured in myelodysplastic syndromes (MDS). Here, we focused on NESCs and glial fibrillary acidic protein (GFAP)-expressing cells in the BM of MDS patients. We found a marked increase of NESCs in MDS with fibrosis (MDS-F) at a high frequency (9/19; 47.4%), but not in MDS without fibrosis (0/26; 0%). Intriguingly, in eight of the nine (88.9%) MDS-F cases with elevated NESCs, a majority of NESCs also expressed GFAP, with an additional increase in GFAP single-positive cells. Furthermore, in seven of them, we found a prominent structure characterized by neurofilament heavy chain staining surrounded by NESCs with GFAP expression. This structure may represent peripheral nerve axons surrounded by Schwann cells, and could be relevant to the pathophysiology of MDS-F.

Identifiants

pubmed: 30632058
doi: 10.1007/s12185-018-02576-9
pii: 10.1007/s12185-018-02576-9
doi:

Substances chimiques

GFAP protein, human 0
Glial Fibrillary Acidic Protein 0
NES protein, human 0
Nestin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

309-318

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 15K15359
Organisme : Japan Society for the Promotion of Science
ID : 17K09898
Organisme : Japan Agency for Medical Research and Development
ID : 18cm0106505h

Références

J Neurosci Res. 1999 May 15;56(4):334-48
pubmed: 10340742
J Cell Sci. 2000 Feb;113 ( Pt 3):383-90
pubmed: 10639326
J Neuropathol Exp Neurol. 2001 Jun;60(6):588-97
pubmed: 11398835
Brain Res. 2002 Jul 12;943(2):174-80
pubmed: 12101039
Cell Mol Life Sci. 2004 Oct;61(19-20):2510-22
pubmed: 15526158
Med Oncol. 2004;21(4):325-31
pubmed: 15579916
N Engl J Med. 2005 Feb 10;352(6):536-8
pubmed: 15703418
J Neurol Sci. 2005 Jun 15;233(1-2):183-98
pubmed: 15896809
Haematologica. 2005 Aug;90(8):1128-32
pubmed: 16079113
Cell. 1990 Feb 23;60(4):585-95
pubmed: 1689217
Cancer Res. 2007 Jan 15;67(2):501-10
pubmed: 17234757
Nat Rev Cancer. 2007 Feb;7(2):118-29
pubmed: 17251918
Pediatr Dev Pathol. 2007 Sep-Oct;10(5):369-82
pubmed: 17929992
Leukemia. 2008 Feb;22(2):313-22
pubmed: 18033321
J Clin Oncol. 2009 Feb 10;27(5):754-62
pubmed: 19103730
Histol Histopathol. 2010 Feb;25(2):177-87
pubmed: 20017104
J Histochem Cytochem. 2010 Aug;58(8):721-30
pubmed: 20421592
Nature. 2010 Aug 12;466(7308):829-34
pubmed: 20703299
Stem Cells. 2010 Dec;28(12):2162-71
pubmed: 20963821
J Cell Physiol. 2012 Feb;227(2):813-20
pubmed: 21503881
Growth Factors. 2011 Oct;29(5):196-202
pubmed: 21740331
Cell. 2011 Nov 23;147(5):1146-58
pubmed: 22118468
Lab Invest. 2012 Sep;92(9):1330-41
pubmed: 22710983
Int J Hematol. 2012 Oct;96(4):438-42
pubmed: 23054646
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Ann Hematol. 2013 Oct;92(10):1335-43
pubmed: 23660629
Nature. 2013 Oct 31;502(7473):637-43
pubmed: 24107994
Leukemia. 2014 Feb;28(2):241-7
pubmed: 24220272
Cell Stem Cell. 2014 Sep 4;15(3):365-375
pubmed: 25017722
Nature. 2014 Aug 7;512(7512):78-81
pubmed: 25043017
Lab Invest. 2014 Nov;94(11):1212-23
pubmed: 25199050
Elife. 2014 Sep 25;3:e03696
pubmed: 25255216
Eur J Haematol. 2015 Sep;95(3):181-9
pubmed: 25600827
Braz J Med Biol Res. 2015 Mar;48(3):207-13
pubmed: 25608238
Trends Neurosci. 2015 Jun;38(6):364-74
pubmed: 25975510
Blood. 2016 Feb 4;127(5):616-25
pubmed: 26637787
Oncotarget. 2016 May 24;7(21):30492-503
pubmed: 27127180
Blood. 2017 Apr 27;129(17):2347-2358
pubmed: 28223278
PLoS One. 2017 Apr 27;12(4):e0176147
pubmed: 28448522
Stem Cell Reports. 2017 Jun 6;8(6):1714-1726
pubmed: 28506533
Front Cell Dev Biol. 2018 Feb 14;6:15
pubmed: 29492403
Science. 1997 Apr 4;276(5309):66-71
pubmed: 9082987
Blood. 1997 Nov 1;90(9):3395-403
pubmed: 9345022

Auteurs

Luan Cao-Sy (L)

Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Department of Molecular Cytogenetics, Blood Transfusion Hematology Hospital, Ho Chi Minh City, Vietnam.

Naoshi Obara (N)

Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Tatsuhiro Sakamoto (T)

Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.

Takayasu Kato (T)

Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Keiichiro Hattori (K)

Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Shingo Sakashita (S)

Department of Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Yasuhito Nannya (Y)

Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Seishi Ogawa (S)

Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Hironori Harada (H)

Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan.

Mamiko Sakata-Yanagimoto (M)

Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Hidekazu Nishikii (H)

Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Shigeru Chiba (S)

Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan. schiba-tky@umin.net.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan. schiba-tky@umin.net.
TARA Center, University of Tsukuba, Tsukuba, Ibaraki, Japan. schiba-tky@umin.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH